Mike Brewster

403 total citations
11 papers, 292 citations indexed

About

Mike Brewster is a scholar working on Pathology and Forensic Medicine, Oncology and Epidemiology. According to data from OpenAlex, Mike Brewster has authored 11 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Mike Brewster's work include Influenza Virus Research Studies (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Mike Brewster is often cited by papers focused on Influenza Virus Research Studies (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Mike Brewster collaborates with scholars based in United Kingdom, Switzerland and Spain. Mike Brewster's co-authors include Kevin L. Wilson, Barbara J Pleuvry, Paul Coulthard, Tatiana V. Macfarlane, Richard A. Robson, Penelope Ward, Kelvin L. Lynn, Adrian L. Buttimore, Christine McIntyre and Pakeeza Sayyed and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Vaccine.

In The Last Decade

Mike Brewster

10 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mike Brewster United Kingdom 8 76 60 57 54 45 11 292
K. Schröder Germany 10 25 0.3× 36 0.6× 24 0.4× 9 0.2× 13 0.3× 38 329
Arash Taheri Iran 11 74 1.0× 94 1.6× 71 1.2× 87 1.6× 58 1.3× 24 342
Don Benson United States 8 289 3.8× 36 0.6× 18 0.3× 27 0.5× 16 0.4× 38 552
Matilda W. Nicholas United States 7 49 0.6× 49 0.8× 50 0.9× 39 0.7× 15 0.3× 25 302
Zeeshan Ali Pakistan 11 130 1.7× 44 0.7× 47 0.8× 31 0.6× 29 0.6× 68 449
Christina Brown Australia 11 66 0.9× 44 0.7× 39 0.7× 81 1.5× 27 0.6× 31 330
Philipp Berning Germany 9 80 1.1× 67 1.1× 24 0.4× 28 0.5× 29 0.6× 21 238
Karen I. Maijer Netherlands 11 39 0.5× 27 0.5× 28 0.5× 64 1.2× 27 0.6× 13 396
Yufeng Shang China 10 108 1.4× 42 0.7× 38 0.7× 38 0.7× 52 1.2× 30 443
Kim Murphy Australia 8 25 0.3× 29 0.5× 27 0.5× 86 1.6× 52 1.2× 12 411

Countries citing papers authored by Mike Brewster

Since Specialization
Citations

This map shows the geographic impact of Mike Brewster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Brewster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Brewster more than expected).

Fields of papers citing papers by Mike Brewster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Brewster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Brewster. The network helps show where Mike Brewster may publish in the future.

Co-authorship network of co-authors of Mike Brewster

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Brewster. A scholar is included among the top collaborators of Mike Brewster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Brewster. Mike Brewster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Salar, Antonio, Irit Avivi, Beate Bittner, et al.. (2014). Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study. Journal of Clinical Oncology. 32(17). 1782–1791. 75 indexed citations
2.
Cortés, Javier, Sandra M. Swain, Iveta Kudaba, et al.. (2013). Absence of pharmacokinetic drug–drug interaction of pertuzumab with trastuzumab and docetaxel. Anti-Cancer Drugs. 24(10). 1084–1092. 19 indexed citations
3.
Felip, Enriqueta, Malcolm Ranson, S. Cedrés, et al.. (2012). A Phase Ib, Dose-Finding Study of Erlotinib in Combination With a Fixed Dose of Pertuzumab in Patients With Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 13(6). 432–441. 16 indexed citations
4.
5.
6.
Davies, Brian E., et al.. (2010). Effect of oseltamivir treatment on anticoagulation: a cross‐over study in warfarinized patients. British Journal of Clinical Pharmacology. 70(6). 834–843. 12 indexed citations
7.
Brewster, Mike, et al.. (2007). Driving Change: The UPS Approach to Business. Medical Entomology and Zoology. 1 indexed citations
8.
Brewster, Mike, James Smith, Regina Dutkowski, & Richard A. Robson. (2006). Active metabolite from Tamiflu® solution is bioequivalent to that from capsule delivery in healthy volunteers: A cross-over, randomised, open-label study. Vaccine. 24(44-46). 6660–6663. 12 indexed citations
9.
Robson, Richard A., Adrian L. Buttimore, Kelvin L. Lynn, Mike Brewster, & Penelope Ward. (2006). The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrology Dialysis Transplantation. 21(9). 2556–2562. 41 indexed citations
10.
Brewster, Mike. (2003). Unaccountable: How the Accounting Profession Forfeited a Public Trust. TU Digital Collections (Thammasat University). 44 indexed citations
11.
Coulthard, Paul, Barbara J Pleuvry, Mike Brewster, Kevin L. Wilson, & Tatiana V. Macfarlane. (2002). Gait analysis as an objective measure in a chronic pain model. Journal of Neuroscience Methods. 116(2). 197–213. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Schröder Breakdown of academic impact, for papers by Arash Taheri Breakdown of academic impact, for papers by Don Benson Breakdown of academic impact, for papers by Matilda W. Nicholas Breakdown of academic impact, for papers by Zeeshan Ali Breakdown of academic impact, for papers by Christina Brown Breakdown of academic impact, for papers by Philipp Berning Breakdown of academic impact, for papers by Karen I. Maijer Breakdown of academic impact, for papers by Yufeng Shang Breakdown of academic impact, for papers by Kim Murphy
Rankless by CCL
2026